title: Role of adjuvant radiation in the management of central neurocytoma: Experience from a tertiary cancer care center of India.
abstract: OBJECTIVE
  Neurocytoma (NC) is a rare benign neuronal tumor. A complete excision remains curative for most of these tumors, but atypical histology and extra-ventricular location often necessitates adjuvant therapy. We intended to explore the clinico-pathological features and treatment outcome in patients of NC in our institute.
  
  
  METHODS
  Medical records were reviewed and data collected on NC over a 6-year period (2006-2012) from the departmental archives. Disease free survival (DFS) was analyzed by Kaplan-Meier method.
  
  
  RESULTS
  A total of 18 patients met the study criteria. Fourteen patients had intra-ventricular neurocytoma (IVNC), right lateral ventricle being the most common site of origin. Gross total resection and near total resection were achieved in eight cases each whereas tumor decompression and biopsy could be done in two cases. On post-operative histopathological examination, eight patients were found to have atypical NC while 10 patients had typical NC. All patients underwent adjuvant radiation. The median dose of post-operative radiation was 56 Gy. All patients were alive at their final follow-up. One patient had both clinical and radiological evidence of local relapse. In the evaluable patients (n = 18), after a median follow-up of 35 months the DFS rate at 2 years and 3 years are 100% and 83% respectively.
  
  
  CONCLUSIONS
  Use of adjuvant radiation to a total dose of 56 Gy enhances the local control and achieves superior survival in patients of NC. Use of 3D conformal planning techniques may help us to achieve better therapeutic ratio in patients with NC.
authors.forename: S
authors.initials: S
authors.lastname: Mallick
authors.affiliation: Department of Radiation Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: S
authors.initials: S
authors.lastname: Roy
authors.forename: S
authors.initials: S
authors.lastname: Das
authors.forename: N P
authors.initials: NP
authors.lastname: Joshi
authors.forename: V
authors.initials: V
authors.lastname: Roshan
authors.forename: A K
authors.initials: AK
authors.lastname: Gandhi
authors.forename: M
authors.initials: M
authors.lastname: Jana
authors.forename: P K
authors.initials: PK
authors.lastname: Julka
authors.forename: G K
authors.initials: GK
authors.lastname: Rath
mesh_terms: D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D002648:Child; D005260:Female; D006801:Humans; D007194:India; D008297:Male; D018306:Neurocytoma / Q000401:mortality / Q000532:radiotherapy*; D018714:Radiotherapy, Adjuvant / Q000379:methods*; D016019:Survival Analysis; D062606:Tertiary Care Centers; D016896:Treatment Outcome; D055815:Young Adult